Skip to content

Aripiprazole

Published: July 26, 2026Updated: July 26, 2026

Aripiprazole is an atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and other mental health conditions. It works by balancing dopamine and serotonin levels in the brain to help improve mood, thinking, and behavior.

Quick summary

Aripiprazole is an atypical antipsychotic that treats schizophrenia and bipolar disorder by modulating dopamine and serotonin activity in the brain.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
N05AX12
RxNorm
89013
Generic
Aripiprazole
Class
atc-n05
Brands
Opipza, Abilify
Availability
rx
Lactation
unknown
Routes
oral
Forms
injection, prefilled syringe, solution, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
15mg once daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
10mg once daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
10mg once daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses exceeding 1000mg may cause serious toxicity
Chronic overdose: Prolonged use above recommended doses can lead to cumulative effects including sedation, metabolic changes, and cardiac effects
Immediate actions
Supportive care, airway management, IV fluids, ECG monitoring, consider activated charcoal if within 1-2 hours
Antidote
No specific antidote exists(Treatment is supportive and symptomatic)
Poison Control: 1-800-222-1222

Special Populations

9 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits significantly outweigh risks; consider discontinuing gradually before planned pregnancy if possible

Monitor

regular fetal monitoring including ultrasound assessments

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh risks; lowest effective dose recommended

Monitor

fetal growth monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use near term if possible; consider dose reduction if discontinuation not feasible

Monitor

fetal monitoring and assessment for neonatal withdrawal symptoms

Use with caution and monitor for adverse effects.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

discontinue breastfeeding or avoid

Key Recommendations

breastfeeding not recommended during aripiprazole therapy; drug is excreted in breast milk

Monitor

if breastfeeding continues, monitor infant for sedation, feeding problems and developmental milestones

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

dose reduction recommended

Key Recommendations

start at low dose (2mg daily) and titrate slowly; not approved for dementia-related psychosis due to increased mortality risk

Monitor

regular assessment of cognitive function, orthostatic hypotension and metabolic parameters

Use with caution and monitor for adverse effects.

⚠

pediatric_age

adolescents 13 17
caution
FDA Category
C
Dose Adjustment

age-specific dosing required

Key Recommendations

approved for schizophrenia (ages 13+) and bipolar disorder (ages 10+); start at 2mg daily titrating to target dose 10-15mg

Monitor

monitor weight, BMI, blood glucose, lipids and prolactin levels; assess for suicidal ideation

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children 6 12
caution
FDA Category
C
Dose Adjustment

age-specific dosing required

Key Recommendations

approved for Tourette's disorder (ages 6+); not approved for schizophrenia or bipolar in this age group; use only if benefits clearly outweigh risks

Monitor

monitor growth velocity, weight, metabolic parameters and extrapyramidal symptoms

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
C
Dose Adjustment

dose reduction required

Key Recommendations

for severe renal impairment (CrCl < 30 mL/min), recommended starting dose is 2mg daily with maximum dose of 15mg daily; use with caution

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate to severe
caution
FDA Category
C
Dose Adjustment

dose reduction required

Key Recommendations

for moderate to severe hepatic impairment (Child-Pugh Class B or C), start with 2mg daily; maximum recommended dose is 15mg daily

Monitor

monitor liver function tests periodically

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:2002

General prescribing information

drug_classWHO
2023

Drug class

Value:Atypical antipsychotic

Drug class information - ATC code N05AX12

usageFDA
2023

Common uses

Value:Schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder irritability, Tourette's syndrome

Common therapeutic uses

mechanismFDA
2023

Mechanism of action

Value:Partial dopamine D2 receptor agonist and serotonin 5-HT1A receptor partial agonist

Pharmacological mechanism

Aripiprazole is FDA-approved for treating schizophrenia in adults and adolescents, bipolar I disorder (manic and mixed episodes), major depressive disorder (as adjunctive therapy), irritability associated with autistic disorder, and Tourette's syndrome.

Aripiprazole functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, while also blocking 5-HT2A receptors. This unique mechanism helps regulate neurotransmitter activity in the brain, improving symptoms of psychosis and mood disorders.

Common side effects include headache, nausea, vomiting, dizziness, and weight gain. Patients should avoid alcohol and be monitored for changes in mood or behavior, including suicidal thoughts, particularly when starting or adjusting dosage.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy